Filter
252
Filtered Results: 252
Text search:
World
Health
Organization,
Global
Polio
Eradication
Initiative
Featured
Recommendations
16
New Publications
91
Language
Document type
No document type
158
Studies & Reports
36
Guidelines
28
Strategic & Response Plan
14
Manuals
8
Training Material
3
Fact sheets
3
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
14
Nigeria
13
India
10
Sierra Leone
8
Liberia
7
Nepal
7
Africa
7
Ethiopia
6
Uganda
6
Pakistan
6
Afghanistan
5
Kenya
5
Namibia
5
Congo, Democratic Republic of
4
Ghana
4
Philippines
4
Malawi
4
Ukraine
4
South Sudan
3
Myanmar / Burma
3
Guinea
2
Senegal
2
Somalia
2
Zambia
2
Syria
2
Indonesia
2
South Africa
2
Bangladesh
2
Middle East and North Africa
2
Latin America and the Carribbean
2
Niger
1
Germany
1
Tanzania
1
Eswatini/ Swaziland
1
Botswana
1
Angola
1
Lesotho
1
Chile
1
South–East Asia Region
1
Western and Central Europe
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
103
Clinical Guidelines
22
Women & Child Health
17
Public Health
14
Key Resources
4
Pharmacy & Technologies
3
Capacity Building
1
Toolboxes
Polio
43
COVID-19
20
Rapid Response
13
Health Financing Toolbox
11
Conflict
8
Global Health Education
7
Disability
6
Ebola
6
Caregiver
5
HIV
4
NTDs
4
Refugee
3
Mental Health
3
Pharmacy
3
AMR
2
Planetary Health
2
NCDs
2
Cholera
1
Natural Hazards
1
TB
1
Specific Hazards
1
The main objectives of the SOPs are to: (i) establish standards and timelines for response activities; and (ii) guide national governments and GPEI partners in key support functions.
This new version of the SOPs presents overall response requirements for dealing with type 1, 2 and 3 poliovirus fo...
Ending Cholera. A global roadmap to 2030
recommended
Ending Cholera—A Global Roadmap to 2030 operationalises the new global strategy for cholera control at the country level and provides a concrete path toward a ... in which cholera is no longer a threat to public health
With a focus on Pakistan and Nigeria’s most vulnerable communities, this report provides insight about the role that community push-back is playing in the transmission of the polio virus and how the Glob... Polio Eradication Initiative (GPEI) can mitigate these social risks to reach every missed child.
The biennium 2020–2021 has revealed more clearly than ever the need for a strong, credible and independent WHO on the world stage. The coronavirus disease (COVID-19) crisis has demonstrated the fundamental importance of the ... detection, response and coordination roles that only WHO can play across all Member States. At the same time, the challenges to global health systems and the pressure to ensure equal access to quality health care and the best health possible for all have mounted. The triple billion targets of the Thirteenth General Programme of Work, 2019–2023 remain relevant. The work of WHO in all contexts has never been more critical. However, as several Member States have pointed out, the COVID-19 pandemic has highlighted the discrepancy between what the world expects of WHO and what it is able to deliver with the resources/capacity it has at its disposal. Sustainable financing is thus a key challenge for the Organization that must be addressed as part of the lessons learned from the current COVID-19 pandemic. Member States discussed this issue in detail during the Seventy-third World Health Assembly and their conclusions were reflected in resolution WHA73.1 (2020). The topic of adequate funding is not new. However, discussions on the matter have, to date, remained rather abstract. Building on previous discussions and taking account of lessons learned, the WHO Secretariat would like to initiate a process aimed at finding a concrete solution to the sustainable financing of WHO. This document proposes a process through which to arrive at such a decision, including the key stages and timeline.
The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to ...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
WHO has a unique combination of technical public health and scientific expertise, and a global operational footprint, with field offices in more than 150 countries. In 2020, this ..., technical, and operational reach meant WHO was able to support countries around the world in every aspect of COVID-19 public health response, from surveillance and laboratory testing to maintaining essential health services in the most vulnerable and fragile contexts.
Many of the countries in the European Region receiving refugees from Ukraine are already offering vaccination services to children and adults. This is important to mitigate the risk of COVID-19 transmission among people travelling or living in close quarters, to protect the refugees from diseases th...
Independent Monitoring Board of the Global Polio Eradication Initiative (Twelfth Report: October...
Guidance for addressing a global infodemic and fostering demand for immunization
December 2020
Misinformation threatens the success of vaccination programs across the world. This guide aims to hel...
The article focuses on "The State of the World’s Children 2023" report published by UNICEF. It highlights the critical role of vaccines in saving lives and the challenges in global immunization ef...
Circulating vaccine-derived poliovirus type 2 in Angola
Ebola virus disease in Democratic Republic of the Congo
Dengue fever in Côte d’Ivoire
Humanitarian crisis in north-east Nigeria.
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively. ...
This results report for the biennium 2020–2021 presents the progress towards the triple billion targets, outcomes and outputs, based on the GPW 13 results framework and indicators. It uses structured methodologies, both quantitative and qualitative, for measuring and analysing the achievements and...
The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality3 SIAs for injectable vaccines and highlight the opportunities to strengthen RI and surveillance. The guide uses measles–rubella SIAs as the main example throughout, but the informatio...
At least half of the world’s population does not have full coverage of essential health services. Health expenses push more than 100 million peop...
